# Importer of Controlled Substances Application: Akorn, Inc.
**ACTION:**
Notice of application.
**DATES:**
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 6, 2020. Such persons may also file a written request for a hearing on the application on or before July 6, 2020.
**ADDRESSES:**
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
**SUPPLEMENTARY INFORMATION:**
In accordance with 21 CFR 1301.34(a), this is notice that on May 14, 2020, Akorn, Inc., 1222 West Grand Avenue, Decatur, Illinois 62522-1412, applied to be registered as an importer of the following basic class(es) of a controlled substance:
| Controlled substance | Drug | Schedule |
| --- | --- | --- |
| Remifentanil | 9739 | II |
The company plans to import the listed controlled substance for research purposes.
William T. McDermott,
Assistant Administrator.